Please login to the form below

Not currently logged in
Email:
Password:

UK Prix Galien opens for entries

Pharma R&D accolades will include a new real world evidence category

Prix Galien 2014 winner Novartis 
Pictured: Novartis pick up the 2014 Innovative Product award

Entries have opened for the 2016 UK Prix Galien Awards, which commend pharmaceutical research and development and celebrate outstanding efforts to improve the human condition through the development of novel, high-value medicines.

Established in 1970, the next outing for the bi-annual prizes will include a new real world evidence category, alongside their well-established accolades for innovative products and orphan product.

The 2014 UK Prix Galien was won by Bexserothe first ever vaccine to treat invasive meningococcal disease, and Sirturo, the first TB medication to be approved in four decades.

The Prix Galien is recognised in 17 countries across Europe and North America, with presences in emerging markets in Asia and Latin America expected soon. The UK Prix Galien franchise is now owned by ValueBase, whose experienced team has a long-standing affiliation with the awards. The 2016 UK judging panel is once again led by Professor Sir Michael Rawlins, chair of the MHRA and founding chair of NICE from 1999 to 2014.

Previous UK Prix Galien winners include well-known brands such as Viagra, Herceptin, Glivec, Xolair, Cervarix and Gardasil. More recent winners, such as Xarelto, Incivo and Victrelis, show how pharmaceutical innovation is helping to transform healthcare services and improve public health.

Registration for entries for the 2016 Awards will close on 29 February 2016, with final submissions due by 29 April 2016, as part of a process that culminates in a ceremony at the House of Commons in September 2016.

For further details on the awards and the entry process visit www.prixgalien.co.uk 

Article by
Dominic Tyer

8th December 2015

From: Research

Share

Tags

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Cello Health

Cello Health’s mission is to help our clients unlock the potential that exists with their assets, brands and organisations in...

Latest intelligence

PM Society Digital Awards – the power of together
Our chief executive, Emma Statham, writes about the value of awards and the power of together....
Seduction_feature_image_thumb.jpg
Seduce anyone in four simple steps
You know the health of the global economy is dependent on our ability to seduce one another – don’t you? And you know that we need to be able to...
What Would Jeremy Do? : Assessing the impact of a Corbyn-led Labour government
GK Strategy are delighted to announce the launch our latest briefing paper entitled ‘What Would Jeremy Do? Assessing the impact of a Corbyn-led Labour government’....

Infographics